HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Geoffrey Oxnard Selected Research
Geoffrey Oxnard Research Topics
Disease
3
Neoplasms (Cancer)
01/2023 - 08/2015
2
Lung Neoplasms (Lung Cancer)
01/2020 - 08/2015
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2023
1
Breast Neoplasms (Breast Cancer)
01/2023
1
Adenocarcinoma
01/2022
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1
Disease Progression
01/2020
1
Acute Kidney Injury (Acute Renal Failure)
01/2020
1
Adenocarcinoma of Lung
08/2015
Drug/Important Bio-Agent (IBA)
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023
1
Circulating Tumor DNA
IBA
01/2023
1
ErbB Receptors (EGF Receptor)
IBA
01/2023
1
atezolizumab
IBA
01/2023
1
Trastuzumab (Herceptin)
FDA Link
01/2022
1
human ERBB2 protein
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazine
IBA
01/2020
1
osimertinib
IBA
01/2020
1
Tyrosine Kinase Inhibitors
IBA
01/2020
1
Cytokine Receptors (Cytokine Receptor)
IBA
08/2015
1
Amino Acids
FDA Link
08/2015
1
Immune Checkpoint Inhibitors
IBA
08/2015
Therapy/Procedure
2
Therapeutics
01/2022 - 08/2015